Put on hold mu­sic: Roche de­lays Spark buy­out for the 9th — and quite pos­si­bly not the last — time

It’s be­gin­ning to take on the will-they-won’t-they char­ac­ter of a sit­com or a vic­to­ri­an nov­el. Nine months af­ter Roche an­nounced it was ac­quir­ing gene ther­a­py pi­o­neer Spark Ther­a­peu­tics, the deal is still not done and to­day, the Swiss gi­ant an­nounced a 9th de­lay.

The an­nounce­ments are be­com­ing a month­ly rou­tine. The last de­lay — at the end of Oc­to­ber — ex­tend­ed the win­dow for ten­ders to pur­chase Spark stock through the com­ing Mon­day, No­vem­ber 25. This new one will push the win­dow un­til De­cem­ber 10.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER